Robust exports of traditional Chinese medicine products so far this year have helped manufacturers mitigate the weaker demand in the domestic market.

Beijing Tong Ren Tang Chinese Medicine Co Ltd, the Hong Kong-based subsidiary of time-honored medicine producer - China Beijing Tong Ren Tang Group Co Ltd, is now increasingly focusing on growing its business overseas after posting a 33 percent year-on-year growth in revenue during the first six months of this year.

"Despite the global economic downturn, our retail revenue and sales have shown steady growth of 24.5 percent and 18.7 percent, respectively, compared with the same period a year ago," the company said in its interim financial report.